Clinical Trials
51 trialsEVITA
Rigshospitalet, Denmark
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
Gruppo Italiano Malattie EMatologiche dell'Adulto
CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS
Zhujiang Hospital
VICTORY
Melbourne Health
A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT
The First Affiliated Hospital of Soochow University
Enhanced Palliative Care in MDS and AML
The University of Hong Kong
Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT
Chinese PLA General Hospital
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
The First Affiliated Hospital of Soochow University
Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies
Centre for Research and Technology Hellas
Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations
First Affiliated Hospital of Jinan University
Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
Loyola University
CALVI
University Hospital, Clermont-Ferrand
Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
University of Campinas, Brazil
Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?
Maastricht University
PRO-DLI
King's College Hospital NHS Trust
NK Cells in Cord Blood Transplantation
M.D. Anderson Cancer Center
AML18
Cardiff University
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
M.D. Anderson Cancer Center
ToTem
University College, London
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
National Taiwan University Hospital
ProT4
University College, London
SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation
Groupe Francophone des Myelodysplasies
TRANSATRA
University Hospital Freiburg
GREFFE
Hospices Civils de Lyon
MacHaploMud
Assistance Publique - Hôpitaux de Paris
CEREAL
Institut Paoli-Calmettes
PANOBEST
Johann Wolfgang Goethe University Hospital
GLIDE
Ciusss de L'Est de l'Île de Montréal
DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
Shanghai Tong Ren Hospital
B7.1/IL-2 Leukaemia Cell Vaccine for Non-Transplant AML RFUSIN2-AML2 (NTX)
King's College London
Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation
Affiliated Hospital to Academy of Military Medical Sciences
A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome
Fujian Medical University
PODAC
Seoul St. Mary's Hospital
Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine
Assistance Publique Hopitaux De Marseille
GFM-Chimio-Rev
Groupe Francophone des Myelodysplasies
B-cell therapy
University of Erlangen-Nürnberg Medical School
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
National University Hospital, Singapore
Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients
Peking University People's Hospital
DFMBHSCT
The First Affiliated Hospital of Soochow University
Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
The First Affiliated Hospital of Soochow University
Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome
Peter MacCallum Cancer Centre, Australia
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
Asan Medical Center
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
McMaster University
DEC-MDS
King's College London
AlloTreo
IRCCS San Raffaele
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor
Colorado Blood Cancer Institute
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
Colorado Blood Cancer Institute